Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher tous les synonymes
these data support a role for the novel PP2Ac-CIN85 complex in supporting integrin-dependent platelet function by dampening the phosphatase activity.
CIN85 promotes recycling of TGF-beta (Montrer TGFB1 Kits ELISA) receptors and thereby positively regulates TGF-beta (Montrer TGFB1 Kits ELISA) signaling.
we demonstrate that SEPT9 (Montrer SEPT9 Kits ELISA) negatively regulates EGFR (Montrer EGFR Kits ELISA) degradation by preventing the association of the ubiquitin ligase Cbl (Montrer CBL Kits ELISA) with CIN85, resulting in reduced EGFR (Montrer EGFR Kits ELISA) ubiquitylation
Results support the model that Cbl (Montrer CBL Kits ELISA)-CIN85-endophilin complex is not required for efficient internalization of EGFR (Montrer EGFR Kits ELISA), a prototype RTK.
Multiple molecular forms of adaptor protein Ruk/CIN85 specifically associate with different subcellular compartments in human breast adenocarcinoma cell line.
LOX (Montrer LOX Kits ELISA)-PP interacts with CIN85 via a novel SH3-binding motif and this association reduces CIN85-promoted invasion by breast cancer cells.
an FRS2beta (Montrer FRS3 Kits ELISA)-CIN85/CD2AP (Montrer Cd2ap Kits ELISA)-Cbl (Montrer CBL Kits ELISA) axis for downregulation of ErbB2 (Montrer ERBB2 Kits ELISA) may regulate ErbB2 (Montrer ERBB2 Kits ELISA) protein levels in physiological and pathological settings
Data show that EGFR (Montrer EGFR Kits ELISA) activation leads to a pronounced src (Montrer SRC Kits ELISA)-mediated tyrosine phosphorylation of CIN85 that subsequently influences EGFR (Montrer EGFR Kits ELISA) ubiquitination.
this study indicates that high levels of Ruk(l)/CIN85 contribute to the conversion of breast adenocarcinoma cells into a more malignant phenotype via modulation of the Src (Montrer SRC Kits ELISA)/Akt (Montrer AKT1 Kits ELISA) pathway.
Data show that CIN85 (c-Cbl interacting protein of 85 kDa) is constitutively associated with c-Cbl (Montrer CBL Kits ELISA), Cbl-b, and B-cell linker (Montrer BLNK Kits ELISA) in B cells.
CIN85/RukL is involved in endocytosis of nephrin (Montrer NPHS1 Kits ELISA) in podocytes under diabetic conditions, causing podocyte depletion and promoting proteinuria. CIN85/RukL expression therefore shows potential to be a novel target for antiproteinuric therapy in diabetes.
Dab1 (Montrer DAB1 Kits ELISA) mediated the association of CIN85 with ApoER2 (Montrer LRP8 Kits ELISA) or VLDLR (Montrer VLDLR Kits ELISA) in neurons.
Data suggest that Ser587 Cin85 phosphomimetic mutant protein shows dramatically reduced binding to Dab1 (Montrer DAB1 Kits ELISA) (disabled protein 1) (without affecting binding to CapZ (Montrer CAPZA1 Kits ELISA)).
Sh3kbp1 is SUMOylated by SUMO-1 (Montrer SUMO1 Kits ELISA), -2, and -3 and that SUMOylation is enhanced in the presence of Cd2ap (Montrer Cd2ap Kits ELISA).
the interaction between SHIP-1 (Montrer INPP5D Kits ELISA) and CIN85 might synergistically facilitate the down-regulation of phosphatidylinositol-3,4,5-trisphosphate levels.
Live cell imaging and co-immunoprecipitation experiments confirmed that both SLP65 (Montrer BLNK Kits ELISA) and CIN85 are both required for the onset and progression phases of B-cell antigen receptor signal transduction.
a B cell-specific deletion of CIN85 led to impaired T cell-independent type II antibody responses in vivo and diminished IKK-beta (Montrer IKBKB Kits ELISA) activation and cellular responses to B (Montrer TDO2 Kits ELISA) cell receptor cross-linking in vitro
Coexpression of CIN85/Ruk(L) with CD2AP (Montrer Cd2ap Kits ELISA) led to a decreased binding of CIN85/Ruk(L) to nephrin (Montrer NPHS1 Kits ELISA) and podocin, which indicates a functional competition between CD2AP (Montrer Cd2ap Kits ELISA) and CIN85/Ruk(L).
Data indicate an important function of CIN85 (SH3KBP1) in the regulation of dopamine D2 receptor (Montrer DRD2 Kits ELISA) functions and provide a molecular explanation for the hyperactive behaviour of CIN85(Deltaex2) mice.
CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases
This gene encodes an adapter protein that contains three N-terminal Src homology domains, a proline rich region and a C-terminal coiled-coil domain. The encoded protein facilitates protein-protein interactions and has been implicated in numerous cellular processes including apoptosis, cytoskeletal rearrangement, cell adhesion and in the regulation of clathrin-dependent endocytosis. Alternate splicing results in multiple transcript variants.
SH3-domain kinase binding protein 1
, SH3 domain-containing kinase-binding protein 1-like
, CD2-binding protein 3
, SH3 domain-containing kinase-binding protein 1
, Src family kinase-binding protein 1
, c-Cbl-interacting protein
, cbl-interacting protein of 85 kDa
, human Src family kinase-binding protein 1
, migration-inducing gene 18
, src-related kinase binding protein-1
, SH3-containing, expressed in tumorigenic astrocytes
, Sh3 containing, expressed in astrocytes
, regulator of ubiquitous kinase
, SH3 domain-containing adapter protein